Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dangerous liaisons: the peri-transplant respiratory microbiota and their impact on lung transplantation outcomes.

Journal of thoracic disease·2026
Same author

Psychometric Performance of Children With Amblyopia During a Tablet-Based Adaptive Visual Acuity Assessment.

Investigative ophthalmology & visual science·2026
Same author

Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity.

iScience·2026
Same author

Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial.

European heart journal·2026
Same author

Effects of psychological stress on skin aging: A literature review.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same author

Artificial Intelligence for predicting adverse surgical outcomes: Challenges, limitations and implications for clinical translation - a narrative review.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026

Related Experiment Video

Updated: Apr 30, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

2.6K

Heart transplantation: challenges facing the field.

Makoto Tonsho1, Sebastian Michel, Zain Ahmed

  • 1MGH Transplantation Center, Massachusetts General Hospital, Boston, Massachusetts 02114.

Cold Spring Harbor Perspectives in Medicine
|May 3, 2014
PubMed
Summary

Heart transplant survival has improved, but long-term outcomes remain poor due to rejection and immunosuppression side effects. Achieving transplant tolerance is key to overcoming these challenges for better patient survival.

More Related Videos

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

776

Related Experiment Videos

Last Updated: Apr 30, 2026

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

2.6K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

776

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Immunology
  • Regenerative Medicine

Background:

  • Heart transplantation survival rates have significantly improved since the 1970s, reaching nearly 90% one-year survival by the 2000s.
  • Long-term outcomes remain suboptimal, primarily due to chronic rejection, malignancy, and the adverse effects of chronic immunosuppression.
  • Emerging challenges include managing complex recipients and antibody-mediated rejection, necessitating novel strategies for long-term success.

Purpose of the Study:

  • To investigate the obstacles to long-term survival in heart transplantation.
  • To explore the potential of inducing transplant tolerance to eliminate the need for chronic immunosuppression.
  • To understand the differential susceptibility of organs to tolerance induction and its implications for xenotransplantation and future therapies.

Main Methods:

  • Review of historical data on heart transplant survival rates and causes of long-term graft failure.
  • Analysis of the immunological mechanisms underlying chronic rejection and immunosuppression-related complications.
  • Comparative assessment of tolerance induction in different solid organ allografts (heart vs. kidney/liver).

Main Results:

  • While short-term survival has dramatically improved, long-term graft survival in heart transplantation is hindered by chronic rejection and immunosuppression toxicity.
  • The heart is identified as a tolerance-resistant organ, unlike kidneys and livers, posing a significant barrier to immunosuppression-free survival.
  • Understanding organ-specific tolerance mechanisms could pave the way for improved strategies in human heart transplantation and pig-to-human xenotransplantation.

Conclusions:

  • Achieving transplant tolerance is crucial for overcoming the limitations of current heart transplantation protocols and improving long-term patient outcomes.
  • Further research into the biological basis of tolerance resistance in cardiac allografts is essential.
  • Alternative future strategies, including mechanical support, stem cells, and bioengineered organs, are progressing and may offer solutions for unlimited long-term circulatory support.